Refractory Acute Lymphoid Leukemia in Relapse
Oncology
Prevalence
7.2 / 100K
Incidence
1.7 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Refractory Acute Lymphoid Leukemia in Relapse?
There are 1 clinical trial targeting Refractory Acute Lymphoid Leukemia in Relapse tracked by BioSniper.
What is the prevalence of Refractory Acute Lymphoid Leukemia in Relapse?
The estimated prevalence of Refractory Acute Lymphoid Leukemia in Relapse is approximately 7.2 per 100,000 population.
Deep-dive into Refractory Acute Lymphoid Leukemia in Relapse
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis